These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 9794410)

  • 21. Alterations in C3 activation and binding caused by phosphorylation by a casein kinase released from activated human platelets.
    Ekdahl KN; Nilsson B
    J Immunol; 1999 Jun; 162(12):7426-33. PubMed ID: 10358196
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structural insights into the central complement component C3.
    Janssen BJ; Gros P
    Mol Immunol; 2007 Jan; 44(1-3):3-10. PubMed ID: 16875735
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Localization of classical and alternative pathway regulatory activity within the decay-accelerating factor.
    Brodbeck WG; Liu D; Sperry J; Mold C; Medof ME
    J Immunol; 1996 Apr; 156(7):2528-33. PubMed ID: 8786315
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A complement C3 fragment equivalent to mammalian C3d from the common carp (Cyprinus carpio): generation in serum after activation of the alternative pathway and detection of its receptor on the lymphocyte surface.
    Nakao M; Miura C; Itoh S; Nakahara M; Okumura K; Mutsuro J; Yano T
    Fish Shellfish Immunol; 2004 Feb; 16(2):139-49. PubMed ID: 15123318
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Functional analysis of Cobra Venom Factor/human C3 chimeras transiently expressed in mammalian cells.
    Kölln J; Matzas M; Jänner N; Mix T; Klensang K; Bredehorst R; Spillner E
    Mol Immunol; 2004 May; 41(1):19-28. PubMed ID: 15140572
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A cluster of positively charged amino acids in the alpha-chain of C4b-binding protein (C4BP) is pivotal for the regulation of the complement system and the interaction with bacteria.
    Blom AM
    Scand J Clin Lab Invest Suppl; 2000; 233():37-49. PubMed ID: 11317941
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human complement factor B: functional properties of a recombinant zymogen of the alternative activation pathway convertase.
    Schwaeble W; Lüttig B; Sokolowski T; Estaller C; Weiss EH; Meyer zum Büschenfelde KH; Whaley K; Dippold W
    Immunobiology; 1993 Jul; 188(3):221-32. PubMed ID: 8225386
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Probing the C1q-binding site on human C-reactive protein by site-directed mutagenesis.
    Agrawal A; Volanakis JE
    J Immunol; 1994 Jun; 152(11):5404-10. PubMed ID: 8189060
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mutations of the type A domain of complement factor B that promote high-affinity C3b-binding.
    Hourcade DE; Mitchell LM; Oglesby TJ
    J Immunol; 1999 Mar; 162(5):2906-11. PubMed ID: 10072540
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CRIT peptide interacts with factor B and interferes with alternative pathway activation.
    Hui KM; Magnadóttir B; Schifferli JA; Inal JM
    Biochem Biophys Res Commun; 2006 May; 344(1):308-14. PubMed ID: 16600177
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of functionally important amino acid sequences in cobra venom factor using human C3/Cobra venom factor hybrid proteins.
    Hew BE; Fritzinger DC; Pangburn MK; Vogel CW
    Toxicon; 2019 Sep; 167():106-116. PubMed ID: 31207349
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Complement C3 isoforms in Austrelaps superbus.
    Rehana S; Kini RM
    Toxicon; 2008 Apr; 51(5):864-81. PubMed ID: 18262580
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dissection of CR1, factor H, membrane cofactor protein, and factor B binding and functional sites in the third complement component.
    Lambris JD; Lao Z; Oglesby TJ; Atkinson JP; Hack CE; Becherer JD
    J Immunol; 1996 Jun; 156(12):4821-32. PubMed ID: 8648130
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structure/function analysis of a dUTPase: catalytic mechanism of a potential chemotherapeutic target.
    Harris JM; McIntosh EM; Muscat GE
    J Mol Biol; 1999 Apr; 288(2):275-87. PubMed ID: 10329142
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Proline residues in transmembrane segment IV are critical for activity, expression and targeting of the Na+/H+ exchanger isoform 1.
    Slepkov ER; Chow S; Lemieux MJ; Fliegel L
    Biochem J; 2004 Apr; 379(Pt 1):31-8. PubMed ID: 14680478
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An extended bipartite nuclear localization signal in Smad4 is required for its nuclear import and transcriptional activity.
    Xiao Z; Latek R; Lodish HF
    Oncogene; 2003 Feb; 22(7):1057-69. PubMed ID: 12592392
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sea urchin coelomocytes specifically express a homologue of the complement component C3.
    Al-Sharif WZ; Sunyer JO; Lambris JD; Smith LC
    J Immunol; 1998 Mar; 160(6):2983-97. PubMed ID: 9510203
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structure and molecular genetics of complement proteins. An update.
    Volanakis JE
    Year Immunol; 1986; 2():164-76. PubMed ID: 3554821
    [No Abstract]   [Full Text] [Related]  

  • 39. Rare loss-of-function mutation in complement component C3 provides insight into molecular and pathophysiological determinants of complement activity.
    Sfyroera G; Ricklin D; Reis ES; Chen H; Wu EL; Kaznessis YN; Ekdahl KN; Nilsson B; Lambris JD
    J Immunol; 2015 Apr; 194(7):3305-16. PubMed ID: 25712219
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mutants of complement component C3 cleaved by the C4-specific C1-s protease.
    Mathias P; Carrillo CJ; Zepf NE; Cooper NR; Ogata RT
    Proc Natl Acad Sci U S A; 1992 Sep; 89(17):8125-9. PubMed ID: 1518837
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.